Details for New Drug Application (NDA): 206513
✉ Email this page to a colleague
NDA 206513 describes ROSUVASTATIN CALCIUM, which is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms Co, Apotex, Aurobindo Pharma Ltd, Biocon Pharma, Cadila Pharms Ltd, Changzhou Pharm, Chartwell Rx, Glenmark Speclt, Hetero Labs Ltd V, Inventia, Lupin, Macleods Pharms Ltd, Mankind Pharma, MSN, Renata, Sandoz, Sciegen Pharms, Shandong, Strides Pharma, Sun Pharm, Sunshine, Teva Pharms Usa, Torrent, Umedica, Watson Labs Inc, Zhejiang Jingxin, and Zhejiang Yongtai, and is included in twenty-nine NDAs. It is available from forty-four suppliers. Additional details are available on the ROSUVASTATIN CALCIUM profile page.
The generic ingredient in ROSUVASTATIN CALCIUM is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.
The generic ingredient in ROSUVASTATIN CALCIUM is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.
Summary for 206513
| Tradename: | ROSUVASTATIN CALCIUM |
| Applicant: | Zhejiang Jingxin |
| Ingredient: | rosuvastatin calcium |
| Patents: | 0 |
Pharmacology for NDA: 206513
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for 206513
Suppliers and Packaging for NDA: 206513
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206513 | ANDA | AiPing Pharmaceutical, Inc. | 11788-130 | 11788-130-05 | 500 TABLET, COATED in 1 BOTTLE (11788-130-05) |
| ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206513 | ANDA | AiPing Pharmaceutical, Inc. | 11788-130 | 11788-130-10 | 1000 TABLET, COATED in 1 BOTTLE (11788-130-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Mar 1, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Mar 1, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
| Approval Date: | Mar 1, 2019 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
